Perimeter Medical Imaging AI, Inc. , a commercial-stage medical technology company, announced the appointment of Ted James, to the newly created position of Chief Medical Officer.
In this fractional role, Dr. James will bring his clinical and leadership experience to help Perimeter strengthen its medical strategy and accelerate adoption of its technology. His perspective as a cancer surgeon and health system executive, combined with his experience in healthcare innovation, will support the company’s growth as it advances toward commercialization.
Health Technology Insights: Long Island Family Doctor Harold Sirota Brings MDVIP to Valley Stream
Dr. James recently became System Physician Executive of the Endeavor Health Cancer Institute after serving as Chief of Breast Surgical Oncology and Director of the Breast Center at Beth Israel Deaconess Medical Center (BIDMC), where he oversaw the growth of a nationally accredited multidisciplinary breast program and developed an NIH-funded research portfolio. He was also Vice Chair of Academic Affairs in the Department of Surgery at BIDMC and an Associate Professor of Surgery at Harvard Medical School. Dr. James received his medical degree from Drexel University, completed his surgical residency at NYU (North Shore–Long Island Jewish), and trained in surgical oncology at Roswell Park Cancer Institute. He also holds a Master of Science in Healthcare Management from the Harvard T.H. Chan School of Public Health.
Health Technology Insights: Longevity Research Boosted by Alamar Biosciences Deal
Dr. James said, “It is a privilege to join Perimeter at such a pivotal time. I have spent much of my career working on ways to improve breast cancer surgery, and margin assessment has always been a challenging problem to solve. What excites me about Perimeter is the chance to put a practical tool in the hands of surgeons that can make a real difference in the operating room. I am looking forward to helping the team bring this technology to the patients who need it.”
“Dr. James brings a unique combination of clinical experience, research leadership, and insight into how care is delivered,” said Adrian Mendes, Perimeter’s Chief Executive Officer. “His expertise will be invaluable as we work to demonstrate the medical and practical value of our next-generation, AI-enabled Perimeter B-Series and advance it toward FDA approval.”
Health Technology Insights: Medecision Acquires of Excell Healthcare Advisors
To participate in our interviews, please write to our HealthTech Media Room at sudipto@intentamplify.com
Source- PR Newswire
